Join CBSET at the Safety Pharmacology Society (SPS) Annual Meeting, September 21-25, at the Centre Mont-Royal, Montreal, Canada.
This year's meeting will be held in partnership with the Canadian Society of Pharmacology and Therapeutics (CSPT). The 2026 meeting will deliver a scientific program aligned with the theme Novel Drug Safety Methodologies: From Bench to Bedside, featuring expert-led symposia, trainee presentations, poster sessions, and an exhibit hall showcasing service and technology providers. This international meeting brings together scientists across academia, industry, government, and clinical practice to connect, share advances, and shape the future of pharmacology and drug safety.
Meet CBSET at the meeting:
CBSET Study Director Donald Hodges, MSc, PhD, DSP, DABT, will be presenting the poster Dose-Dependent Pharmacokinetics, Tissue Distribution, and Tolerability of PEGylated Gold Nanorods (SivaRods™) Following Intravenous Administration in Rats.
David Parrillo, Senior Account Executive for Business Development at CBSET, will be attending.
Related Publications:
Maximizing insights from nonclinical safety studies in the context of rising costs and changing regulations. Donald Hodges, Michael Stonerook, Dany Salvail, Sandrine Lemouton. Journal of Pharmacological and Toxicological Methods. Volume 128, July–August 2024, 107538.
Ototoxicity: a high risk to auditory function that needs to be monitored in drug development. Marie-Pierre Pasdelou, Lise Byelyayeva, Susanna Malmström, Sylvie Pucheu, Marie Peytavy, Hugo Laullier, Donald B. Hodges, Abraham R. Tzafriri, Gaëlle Naert. Frontiers in Molecular Neuroscience, May 2, 2024.
HEAR THIS! Potential Therapeutics for COVID-19 Should Be Tested for Auditory Safety. Michael Naimark, Director of Business Development, CBSET; Wahid Awad, PhD, Chief Business Officer, Cilcare. World Pharma Today, August 24, 2020.
Auditory Therapy, Ototoxicity, and GLP Compliance: Will the promising market for ear disorder treatments follow ophthalmology’s dramatic growth curve? Michael Naimark, Director of Business Development, CBSET; Marie-Pierre Pasdelou, founder and the Chief Development Officer, Cilcare. World Pharma Today, November 1, 2017.